Drugs that contain Dasatinib

1. Drug name - SPRYCEL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7491725 BRISTOL MYERS SQUIBB Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
Mar, 2026

(3 years from now)

CN1980909B BRISTOL MYERS SQUIBB As Kinase Inhibitor 2-Amino Thiazole -5 - Aromatic Methanamide Preparation Method
Feb, 2022

(7 months ago)

CN1980909A BRISTOL MYERS SQUIBB Preparation Method Of 2-Aminothiazole-5-Aromatic Methanamide Regarded As Kinase Inhibiter
Feb, 2022

(7 months ago)

EP1711481A2 BRISTOL MYERS SQUIBB Process For Preparing 2-Aminothiazole-5-Aromatic Carboxamides As Kinase Inhibitors
Feb, 2025

(2 years from now)

EP1711481B2 BRISTOL MYERS SQUIBB Crystalline Monohydrate As Kinase Inhibitors
Feb, 2025

(2 years from now)

EP1711481B1 BRISTOL MYERS SQUIBB Crystalline Monohydrate As Kinase Inhibitors
Feb, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8680103 BRISTOL MYERS SQUIBB Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors Feb, 2025

(2 years from now)

US8680103

(Pediatric)

BRISTOL MYERS SQUIBB Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors Aug, 2025

(2 years from now)

US7491725

(Pediatric)

BRISTOL MYERS SQUIBB Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors Sep, 2026

(4 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
20MG TABLET;ORAL Prescription
50MG TABLET;ORAL Prescription
70MG TABLET;ORAL Prescription
80MG TABLET;ORAL Prescription
100MG TABLET;ORAL Prescription
140MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.